About Kritika Sarmah
Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist.
She earned her bachelor's degree in commerce and is currently pursuing the CFA program.
With her fundamental approach, she aims to help investors identify untapped investment opportunities.
Recent Articles By Kritika Sarmah
3 Biotech Stocks Gaining Altitude and Interest
This year, the biotech industry anticipates a resurgence with increased M&A, FDA approvals, and AI-driven innovations. Given the industry’s rosy prospects, biotech stocks BioMarin Pharmaceutical (BMRN), ANI Pharmaceuticals (ANIP), and Genmab A/S (GMAB), gaining significant altitude and interest, could be ideal buys. Read on...
3 Energy Stock Buys Surging Past Expectations
Rising oil prices due to escalating geopolitical tensions and supply concerns should bode well for the energy sector. So, I think fundamentally solid energy stocks Energy Transfer (ET), Pembina Pipeline (PBA), and Matrix Service (MTRX) might be ideal buys. Read more...
4 Pharma Giants Sparking Investor Interest
The pharmaceutical industry is growing steadily, focusing more on technological innovation, precision medicine, and strategic mergers and acquisitions (M&A). So, let’s take a look at pharma giants Novo Nordisk A/S (NVO), Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) igniting investor interest. Keep reading…
BlackRock (BLK) Pre-Earnings Outlook - Hold or Sell?
With $10 trillion in AUM and upcoming acquisitions, Investment Giant BlackRock’s (BLK) long-term prospects shine bright. However, macroeconomic challenges exist. As the company gears up to unveil its earnings this Friday, let us analyze whether the stock is a Hold or Sell…
Is Constellation Brands (STZ) Preparing for an Earnings Boost?
The prominent alcohol beverage company, Constellation Brands (STZ), is preparing to unveil its fiscal third-quarter earnings this week. While the alcohol beverage market is growing, intense competition may present challenges for STZ. Let's delve into its fundamentals to determine if the stock is primed for a surge this week…
3 Tech Stocks Set to Soar Beyond Expectations
The technology sector’s significant growth is fueled by continued technological innovation, Gen Z's mobile habits, and rising demand for versatile devices. Hence, it could be wise to invest in tech stocks Canon (CAJPY), Zoom Video Communications (ZM), and Brother Industries (BRTHY), which are poised to surpass expectations. Continue reading...
Canopy Growth (CGC) vs. Novo Nordisk (NVO): Which Pharma Stock Is a Better Investment?
The Pharma sector’s innovative trial methodologies and shift toward customized medicine signal transformative growth potential in the pharmaceutical industry. While leading Pharma stocks Canopy Growth (CGC) and Novo Nordisk (NVO) stand to benefit, let us analyze which of them is a better investment...
3 Specialty Retailer Stocks Setting the Pace for April Gains
The specialty retailer sector embraces technological innovation and resilient sales trends, navigating changing consumer preferences with adaptability. Therefore, investors could consider buying quality specialty retailer stocks SK Murphy USA (MUSA), Torrid Holdings (CURV), and The ODP Corporation (ODP) in April for solid gains. Read more…
Snap (SNAP) vs. TripAdvisor (TRIP): Comparing Internet Stocks for Long-Term Investment
The internet is now an essential part of our lives, and there is a growing need for reliable, cutting-edge services. With that in mind, let us analyze internet stocks Snap (SNAP) and TripAdvisor (TRIP) to determine the ideal pick for long-term investment...